Morgan, Rhian M, Parry, Allyson M M, Arida, Ricardo M et al. · Psychopharmacology · 2007 · DOI
This study looked at how a dietary supplement called tryptophan affects the brain's activity during mental tasks in people experiencing central fatigue (like in ME/CFS). Researchers used brain imaging to watch what happens when people take tryptophan versus a placebo while doing a challenging attention test. They found that tryptophan slowed down responses and changed brain activity patterns in several regions, particularly in areas related to awareness and processing information.
Understanding the brain mechanisms underlying central fatigue is crucial for ME/CFS patients, as cognitive difficulties are a hallmark symptom. This study provides neuroimaging evidence that central fatigue involves changes throughout multiple brain networks, not just in one location, which could help researchers develop better targeted treatments. Identifying how specific metabolites affect brain function during cognitive tasks may eventually lead to interventions that reduce the cognitive burden experienced by ME/CFS patients.
This study does not prove that tryptophan causes central fatigue or that tryptophan abnormalities are the primary driver of fatigue in ME/CFS. The small sample size (n=8) and acute tryptophan administration do not establish whether chronic tryptophan dysregulation plays a role in the condition. The observed brain activity changes are correlational and do not demonstrate whether these changes are beneficial, harmful, or simply incidental to the fatigue experience.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →